Zoligratinib

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NameZoligratinib

Drug Alias NameCH-5183284FF-284Debio-1347

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFibroblast growth factor receptor 3 antagonistsFibroblast growth factor receptor 1 antagonistsFibroblast growth factor receptor 2 antagonists

TargetsFibroblast growth factor receptor 1Fibroblast growth factor receptor 3Fibroblast growth factor receptor 2

Therapy Area/IndicationsSolid tumoursBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaBulgariaUnited States +[23]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesChugai Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesDebiopharm International Sa

Inactive CompaniesN/A

Active IndicationsBreast Neoplasms

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A